David M. Waterhouse, MD, MPH, is a medical oncologist and hematologist whose specialties include lung cancer and urologic cancer. Dr. Waterhouse is passionate about cancer research and the impact it has on patients. This is evidenced by his extensive commitments: Chair of ASCO State of Oncology Care in America (SOCCA) Committee, Director of OHC’s Early Phase Clinical Trials, and as principal investigator of phase one trials. His intense drive and passion have been recognized by ASCO as the winner of the Clinical Trials Participation Award, the Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology, and as an international lecturer on immunotherapy drugs. He is also the recipient of the Unsung Hero Award from Cancer Family Care and the Healthcare Hero Innovator Award from the Cincinnati Business Courier.